Clinical Trials Logo
  1. Home
  2. Peripheral Artery Disease (PAD)
  3. NCT05941533

Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease

Peripheral Artery Disease (PAD) Clinical Trial

Official title:
Infrared Thermal Imaging in Evaluating the Percutaneous Transluminal Angioplasty for Peripheral Artery Disease

Clinical Trial Summary

Determination of IRTI (infrared thermal imaging) can be used to evaluate PAD patients with critical limb ischemia with different degrees of lesion. IRTI can be used to evaluate the foot blood perfusion after percutaneous transluminal angioplasty (PTA) treatment and determine the success rate of surgery. IRTI can be used as an effective follow-up tool for patients after surgery.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT05941533
Study type Observational
Source The First Affiliated Hospital of Guangzhou Medical University
Contact
Status Recruiting
Phase
Start date March 1, 2023
Completion date June 1, 2024
View Details
See also
  Status Clinical Trial Phase
Terminated NCT02227368 - Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR Phase 2
Completed NCT03744572 - Prestige Pilot - Phoenix Atherectomy and Stellarex DCB Clinical Investigation in Infrapopliteal Interventions
Recruiting NCT06052319 - A Study to Assess the Engagement and Usefulness of Care4Today Digital Platform for Disease Management in Coronary Artery Disease (CAD) and/or Peripheral Artery Disease (PAD) Population
Active, not recruiting NCT02924857 - The Chocolate Touch Study N/A
Not yet recruiting NCT05665816 - Results of the Treatment of Medium and Long de Novo and Restenotic Lesions in the Superficial Femoral Artery and/or Popliteal Artery With Primary or Salvage Pulsar® -18 t3 Stent
Active, not recruiting NCT04821388 - Α Pre CE-Marking Study Using the Rontis Drug Coated Balloon for Treatment of Lesions in Femoropopliteal Arteries N/A
Recruiting NCT03304821 - Granulocyte-Macrophage Stimulating Factor (GM-CSF) in Peripheral Arterial Disease Phase 2
Completed NCT02220686 - Vascular Physician Offer and Report (VAPOR) Trial N/A